Phreesia’s Study Highlights Key Role of Patient Outreach
Phreesia's Research on Vaccine Outreach Strategies
Phreesia, a leader in patient activation, recently conducted a significant study analyzing over 20.2 million digital communications about vaccines. This research particularly highlights how delivering vaccine-related information to adults and caregivers right before medical appointments can enhance vaccine confidence and increase vaccination rates, notably among historically marginalized communities.
Key Findings from the Study
Phreesia's outreach program ran from March 2020 through May 2024, reaching patients across the country in various healthcare settings. By segmenting patients according to demographics and vaccination history, the company effectively tailored its messages to target hesitancy and promote vaccine uptake, including initial vaccinations and booster shots. The findings were recently shared at a prestigious immunization conference.
Impressive Vaccination Rates
The study revealed compelling data: patients exposed to point-of-care messages had vaccination rates that were more than double those of the control groups who did not receive such information. A notable 49% of individuals who engaged with these messages described the information as new, and 65% expressed an increased likelihood of discussing vaccines with their healthcare providers.
Transforming Patient Attitudes and Behaviors
Exposure to these messages significantly influenced patient knowledge and behaviors regarding vaccinations. In some cases, the data showed that when patients received information via point-of-care channels, the vaccination rates surged over ten times compared to those not informed. This transformation speaks volumes about the potential impact of direct, relevant communication during healthcare visits.
The Importance of Reliable Information
During a time of increasing vaccine hesitancy fueled by misinformation—especially surrounding COVID-19—Phreesia's findings underscore the necessity of providing accurate and clear vaccine information. Throughout the pandemic, childhood vaccination rates have suffered, leading to concerning levels far below those required for herd immunity in various states.
Engagement at Critical Decision Moments
Jai Seth, Phreesia’s Associate Director of Strategic Research, emphasized the critical role of patient engagement at the point of care, stating that continuous research in this area will help pave the way for innovative outreach methods. He stressed the ongoing need to influence vaccine attitudes positively during these pivotal health discussions.
Voices from Leadership
David Linetsky, Senior Vice President of Life Sciences at Phreesia, shared his insights on how empowering patients with timely vaccine information can lead to more educated health decisions that not only protect individuals but also benefit public health at large. Christina Suh, MD, MPH, a pediatrician at Phreesia, endorsed the notion that simple, tailored reminders play an essential role in advancing immunization initiatives.
About Phreesia
Phreesia has emerged as a trusted partner in patient activation, partnering with healthcare providers, life sciences companies, and payers to create tools that empower patients in their healthcare journey. Established in 2005, Phreesia facilitated around 150 million patient visits in a recent year—more than 10% of all visits across the U.S. With a commitment to delivering patient-driven digital solutions for intake, outreach, and education, Phreesia aims to enhance patient experiences and improve healthcare outcomes.
Frequently Asked Questions
What is the main focus of Phreesia's research?
Phreesia's research primarily focuses on how point-of-care patient outreach can enhance vaccine confidence and uptake among patients.
How does point-of-care messaging affect vaccination rates?
Patients exposed to point-of-care messages showed vaccination rates over double compared to those who did not receive such messages.
What percentage of patients found the information new?
According to the study, 49% of patients indicated that the information they received was new to them.
Why is patient engagement at the point of care important?
Engaging patients at the point of care is crucial for influencing their health decisions and enhancing their understanding of vaccines, which can lead to improved vaccination rates.
What is Phreesia’s goal in the healthcare sector?
Phreesia aims to empower patients to take an active role in their healthcare, leading to better health outcomes through informed decision-making.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Concord Medical Financial Update: First Half of 2024 Insights
- Welshare Health's New AI App Revolutionizes Patient Research
- Calian Group Partners with Microsoft for Cloud Cybersecurity Solutions
- Flow Beverage Corp. Set for Key Investor Conference Engagement
- Deloitte Celebrates Recognition as ESG Firm of the Year
- Celebrating 75 Years of the People's Republic of China
- Barclays Highlights China’s Stimulus Effects on Markets
- Dupixent's New Approval in China: A Breakthrough for COPD Patients
- Understanding the Nomination Board of Lassila & Tikanoja plc
- Xinghe Intelligent WAN: Pioneering the Future of Connectivity
Recent Articles
- Knowles Corporation Announces Strategic Sale of CMM Business
- Growth Trajectory of the Pet Stem Cells Market Explained
- Global Growth in Maritime Awareness Systems Projected at $4B
- Exploring the Incredible Income Potential of YieldMax ETFs
- Global House and Floor Cleaner Market Set to Surge to $24 Billion
- Exploring Growth in the Electronic Board Level Market
- Growth Surge in Automatic Immunoassay Analyzers Expected
- Automated Biochemical Analyzers Market Sees Rapid Growth
- Signing Day Sports Expands Horizon with Swifty Global Acquisition
- W&T Offshore's Latest ESG Report Reflects Commitment to Sustainability
- noco-noco Inc Unveils 2025 Business Restart Strategy for Growth
- New Advances in Niobium-Titanium Alloys for Fuel Cell Applications
- Exploring WisdomTree's Diverse Fund Performance Metrics
- GC Therapeutics Launches Innovative iPSC Cell Therapy Platform
- Vecima Networks Inc. Achieves Remarkable Growth in Fiscal 2024
- NGL Energy Partners LP Distributes Quarterly Dividends for Units
- Granite Telecommunications Unveils New Headquarters Facility
- Hyperscale Data Announces Dividend for Preferred Stock Holders
- Innovative White Paper Unveils AI Impact on Drug Safety
- noco-noco Inc Unveils Ambitious Restart Plan for Future Growth
- Alibaba's Stock Surges on Launch of New AI Innovations and Tools
- Yutong Bus Proves Resilience in Harsh Heat Trials
- Infinix Reports Rapid Growth With 18.8% Increase in Q2 Shipments
- Pudu Robotics Launches the Innovative PUDU D7 Semi-Humanoid Robot
- Innovative Insights on Reviving Aged Egg Cells for IVF Success
- Legal-Bay Transforms Lawsuit Funding with Swift Cash Advances
- Target Appoints Jim Lee as Chief Financial Officer
- Innovative AI Solutions Unveiled by S&P Global Market Intelligence
- BioCentriq Welcomes New CEO Syed T. Husain to Lead Growth
- Mendel AI Unveils Hypercube on Snowflake AI Data Cloud
- Insights on Restoring America’s Uranium Enrichment Capabilities
- Pudu Robotics Launches Revolutionary PUDU D7 Semi-Humanoid Robot
- Yutong Bus Thrives in Extreme Heat, Showcases Innovation and Safety
- Indian Stock Market Surges as Nifty 50 and BSE Sensex Climb
- BofA Optimistic About CrowdStrike's Growth Despite Challenges
- Revised Perspectives on Computershare Limited Amid Market Changes
- Berenberg Rates Ashtead Stock Highly Amid Growth Opportunities
- Expert Tips for a Fulfilling Retirement You Can Embrace
- Surge of Optimism in U.S. Banking Sector Following Rate Cuts
- Wells Fargo Strategists Predict S&P 500's Range-Bound Future
- BCA Research Questions US Economy's Resilience Against Recession
- Federal Reserve Initiates Easing Cycle with 50bps Rate Cut
- Bullish Billionaires Propel Bitcoin Prices Towards New Heights
- Nio: Accelerating Growth Amidst Market Challenges
- Analyzing Market Trends After Recent Fed Interest Rate Changes
- TotalEnergies Enhances LNG Partnership with CNOOC for Future Growth
- Plug Power's Recent Growth Driven by Green Hydrogen Projects
- August 2024 Rental Report: Trends in Affordability Across the U.S.
- Rock Tech Advances Lithium Conversion Plans in North America
- Rokmaster Resources Expands Mystery Property by 4,098 Hectares